Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
4.640
-0.140 (-2.93%)
At close: Mar 11, 2025, 4:00 PM
4.884
+0.244 (5.26%)
After-hours: Mar 11, 2025, 6:00 PM EST
Serina Therapeutics Employees
As of December 31, 2023, Serina Therapeutics had 11 total employees, including 9 full-time and 2 part-time employees.
Employees
11
Change
n/a
Growth
n/a
Revenue / Employee
$287,045
Profits / Employee
-$668,104
Market Cap
45.90M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 11 | - | - |
SER News
- 27 days ago - Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of Directors - GlobeNewsWire
- 5 weeks ago - Serina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients - GlobeNewsWire
- 7 weeks ago - Serina Therapeutics Announces Sale of UniverXome Subsidiary - GlobeNewsWire
- 2 months ago - Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors - GlobeNewsWire
- 3 months ago - Serina Therapeutics to Present at Tribe Public's Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024 - GlobeNewsWire
- 3 months ago - Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit - GlobeNewsWire
- 3 months ago - Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients - GlobeNewsWire
- 4 months ago - Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewsWire